pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 8·1 min read
save

ADA conference sees data presentations and police escort of members over editorial distribution

Jun 8, 2026·read at STAT ↗Neutral

The American Diabetes Association held its annual meeting in New Orleans, concluding three days of sessions that featured new data readouts and scientific presentations.

Attendees heard updates on diabetes research and treatment advances, though the article does not detail specific trial outcomes.

Later in the day, several ADA members were removed from the convention center after attempting to distribute an editorial that criticized policies of the Trump administration. The organization’s media team said the members had breached the event’s code of conduct, and the editorial had originally appeared in the ADA’s Diabetes Care journal.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Major readouts from the annual diabetes conference”

read at STAT ↗
1,182 words · retrieved Jun 8
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
BOEHRINGER INGELHEIMBoehringer Ingelheim CorpELI LILLY COLILLYMassachusetts General HospitalPFIZERUNIQUE
drugs
Obesity3
topics
Type 2 Diabetes8Obesity3Infectious Disease2Psychiatry & CNS2GLP-1 receptorGene Therapy (AAV)

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Jun 7STAT+: New data may cast doubt on competitiveness of Boehringer’s obesity drugSTAT
  • Dec 22Fierce Biotech Fundraising Tracker '26: Superluminal snags $60M; AusperBio adds $120MFierce Biotech
  • Jun 9Gilead and Merck’s latest trial success and flopSTAT
  • Jun 4STAT+: Pharmalittle: We’re reading about fewer pharma investments in Germany, growing U.S. layoffs, and moreSTAT